The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism

被引:27
|
作者
Ng, Austin Chin Chwan [1 ]
Adikari, Dona [1 ]
Yuan, David [1 ]
Lau, Jerrett K. [1 ]
Yong, Andy Sze Chiang [1 ]
Chow, Vincent [1 ]
Kritharides, Leonard [1 ]
机构
[1] Univ Sydney, Dept Cardiol, Concord, NSW, Australia
来源
PLOS ONE | 2016年 / 11卷 / 03期
基金
英国医学研究理事会;
关键词
RISK-FACTORS; OUTCOMES; MODELS; TERM;
D O I
10.1371/journal.pone.0150448
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Symptomatic pulmonary embolism (PE) is a major cause of cardiovascular death and morbidity. Estimated prevalence and incidence of atrial fibrillation (AF) in developed countries are between 388-661 per 100,000, and 90-123 per 100,000 person-years respectively. However, the prevalence and incidence of AF in patients presenting with an acute PE and its predictors are not clear. Methods Individual patient clinical details were retrieved from a database containing all confirmed acute PE presentations to a tertiary institution from 2001-2012. Prevalence and incidence of AF was tracked from a population registry by systematically searching for AF during any hospital admission (2000-2013) based on International Classification of Disease (ICD-10) code. Results Of the 1,142 patients included in this study, 935 (81.9%) had no AF during index PE admission whilst 207 patients had documented baseline AF (prevalence rate 18,126 per 100,000; age-adjusted 4,672 per 100,000). Of the 935 patients without AF, 126 developed AF post-PE (incidence rate 2,778 per 100,000 person-years; age-adjusted 984 per 100,000 person-years). Mean time from PE to subsequent AF was 3.4 +/- 2.9 years. Total mortality (mean follow-up 5.0 +/- 3.7 years) was 42% (n = 478): 35% (n = 283), 59% (n = 119) and 60% (n = 76) in the no AF, baseline AF and subsequent AF cohorts respectively. Independent predictors for subsequent AF after acute PE include age (hazard ratio [HR] 1.06, 95% confidence interval [CI] 1.04-1.08, p<0.001), history of congestive cardiac failure (HR 1.88, 95% CI 1.12-3.16, p = 0.02), diabetes (HR 1.72, 95% CI 1.07-2.77, p = 0.02), obstructive sleep apnea (HR 4.83, 1.48-15.8, p = 0.009) and day-1 serum sodium level during index PE admission (HR 0.94, 95% CI 0.90-0.98, p = 0.002). Conclusions Patients presenting with acute PE have a markedly increased age-adjusted prevalence and subsequent incidence of AF. Screening for AF may be of importance post-PE.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] INCIDENCE OF CEREBRAL EMBOLISM AND PLATELET-FUNCTION IN PATIENTS WITH ATRIAL-FIBRILLATION
    FUKUDA, T
    ICHIKAWA, H
    SEKIYA, T
    NAKAMURA, M
    SANO, T
    IRIE, S
    SAITO, T
    INAGAKI, Y
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1988, 52 (08): : 857 - 857
  • [32] OCCULT THYROTOXICOSIS IN PATIENTS WITH ATRIAL-FIBRILLATION AND AN ACUTE ARTERIAL EMBOLISM
    MONREAL, M
    LAFOZ, E
    FOZ, M
    SANMARTI, A
    SALINAS, I
    AUDI, L
    VIVER, E
    ANGIOLOGY, 1988, 39 (11) : 981 - 985
  • [33] Peripheral embolism in patients with atrial fibrillation
    Avram, R
    Branzan, L
    Ivan, V
    Nicolin, M
    Rosu, D
    Tudoran, M
    Turcan, M
    Balint, M
    Parv, F
    Motoc, D
    Avram, J
    PROCEEDINGS OF THE 14TH CONGRESS OF THE EUROPEAN CHAPTER OF THE INTERNATIONAL UNION OF ANGIOLOGY, 2001, : 545 - 550
  • [34] Acute pulmonary embolism or paroxysmal atrial fibrillation in patients with heart failure and preserved ejection fraction: prognostic implications
    Tufano, Nicola
    De Turris, Salvatore
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [35] Incidence of Subsequent Acute Coronary Syndrome in Patients With Atrial Fibrillation
    Shroff, Gautam R.
    Heubner, Brooke M.
    Schein, Jeff
    Crivera, Concetta
    Herzog, Charles A.
    CIRCULATION, 2012, 126 (21)
  • [36] Acute pulmonary embolism or paroxysmal atrial fibrillation in patients with heart failure and preserved ejection fraction: prognostic implications
    Tufano, Nicola
    De Turris, Salvatore
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [37] Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation
    Schrickel, Jan Wilko
    Lickfett, Lars
    Lewalter, Thorsten
    Mittman-Braun, Erica
    Selbach, Stephanie
    Strach, Katharina
    Naehle, Claas P.
    Schwab, Joerg Otto
    Linhart, Markus
    Andrie, Rene
    Nickenig, Georg
    Sommer, Torsten
    EUROPACE, 2010, 12 (01): : 52 - 57
  • [38] Paroxysmal Atrial Fibrillation in the Course of Acute Pulmonary Embolism: Clinical Significance and Impact on Prognosis
    Krajewska, Agnieszka
    Ptaszynska-Kopczynska, Katarzyna
    Kiluk, Izabela
    Kosacka, Urszula
    Milewski, Robert
    Krajewski, Jacek
    JerzyMusial, Wlodzimierz
    Sobkowicz, Bozena
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [39] PREVALENCE AND INCIDENCE OF PULMONARY ARTERIAL EMBOLISM IN PATIENTS WITH DEEP VENOUS THROMBOSIS
    OBERNOSTERER, A
    PILGER, E
    LIPP, R
    DECRINIS, M
    LAFER, M
    DODER, A
    TISCHLER, R
    ASCHAUER, M
    STARK, G
    VASA-JOURNAL OF VASCULAR DISEASES, 1992, : 38 - 39
  • [40] Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients
    Wilke, Thomas
    Groth, Antje
    Mueller, Sabrina
    Pfannkuche, Matthias
    Verheyen, Frank
    Linder, Roland
    Maywald, Ulf
    Bauersachs, Rupert
    Breithardt, Guenter
    EUROPACE, 2013, 15 (04): : 486 - 493